Evimeto AM Tablet PR is a combination medication containing Amlodipine 5mg and Metoprolol Succinate 50mg, designed to effectively manage hypertension and angina pectoris. Amlodipine, a calcium channel blocker, works by relaxing blood vessels, thereby reducing blood pressure and improving blood flow. Metoprolol Succinate, a beta-1 selective beta-blocker, decreases heart rate and cardiac output, further aiding in blood pressure control and reducing the heart's oxygen demand. This dual-action formulation provides a synergistic effect, making it suitable for patients who require more than one antihypertensive agent for optimal blood pressure management. Evimeto AM Tablet PR is typically prescribed for patients with essential hypertension, chronic stable angina, and other cardiovascular conditions where combination therapy is indicated. The prolonged-release formulation ensures a steady release of active ingredients, promoting better compliance through once-daily dosing and minimizing fluctuations in drug levels. Patients should take this medication under medical supervision, as dosage adjustments may be necessary based on individual response and tolerance. Common side effects may include dizziness, fatigue, and mild swelling, but serious adverse effects are rare when used as directed. Regular monitoring of blood pressure and heart rate is recommended during treatment with Evimeto AM Tablet PR.